Re-visiting the Role of Pneumococcal Vaccination in Patients with Cardiovascular Diseases Dr. Sanjay Mittal14 May 2025 11:37 AM ISTCardiovascular diseases (CVD) account for 24.8% of all deaths in India, with an age-standardized death rate of 272 per 100,000-higher than the global...
Intranasal Corticosteroids in Allergic Rhinitis: Indian ENT Perspective and Utility of Fluticasone Furoate Dr. Kamal Kant Kohli3 Jan 2025 11:00 AM ISTAllergic Rhinitis (AR), one of the most prevalent types of chronic rhinitis, has marked symptoms of nasal congestion, itching, rhinorrhoea, sneezing,...
Efficacy and Safety of Montelukast with Fexofenadine in Allergic Rhinitis Dr. Kamal Kant Kohli29 Nov 2024 11:58 AM ISTAllergic Rhinitis (AR) can be an intermittent or persistent, seasonal or perennial immunologic inflammatory condition affecting the nasal mucosa....
Practice Patterns About Management of Allergic Rhinitis: Indian HCP KAP Experience in 2024 and Preference of Fexofenadine and Montelukast Dr. Kamal Kant Kohli29 Oct 2024 10:00 AM ISTAllergic Rhinitis (AR) is the most common immune-mediated inflammatory condition affecting the nasal mucosa (1) triggered by the production of IgE...
Revolutionizing COPD Care: The Role Of Pneumococcal Vaccines in Enhancing Patient Outcomes Dr Rajesh V11 Oct 2024 12:00 PM ISTExacerbations are recognized to be crucial acute events that are associated with increased hospitalization rates and worsening clinical outcomes. Both...
Role of Cefepime Enmetazobactam in HAP Dr. Kamal Kant Kohli25 Sept 2024 11:30 AM ISTKey Takeaways:Hospital-acquired pneumonia (HAP) is associated with significant morbidity, mortality, and increased healthcare costs.Common pathogens...
Allergen Patterns in Moderate to Severe Allergic Rhinitis: Indian Observations and Therapeutic Utility of Fexofenadine Dr. Kamal Kant Kohli21 Aug 2024 12:00 PM ISTAllergic diseases are a major public health concern globally including in India with more than 25% of the population being sensitized to varied...
Allergic Rhinitis and ENT Practice: Review and Evidence Emphasis on Fluticasone Furoate Dr. Kamal Kant Kohli11 July 2024 12:00 PM ISTAllergic rhinitis (AR) affects approximately 25% and 40% of children and adults globally, respectively. In 80% of the cases, the symptoms occur before...
Exploring the Role of Cefuroxime in Treatment of Upper Respiratory Tract Infections within ENT Outpatient Settings Dr. Kamal Kant Kohli24 Jun 2024 11:30 AM ISTUnderstanding the Impact and Epidemiology of Upper Respiratory Tract Infections: Upper respiratory tract infections (URTIs) are inflammation of the...
Allergic Rhinitis and Co-morbid Asthma: All Clinician Needs to Know and Consideration of Fexofenadine and Montelukast Combination Dr. Kamal Kant Kohli6 May 2024 11:30 AM ISTAllergic rhinitis (AR), a prevalent non-infectious disease condition; is an IgE-mediated response to allergens, causing symptoms like sneezing,...
Allergic Rhinitis: Challenges, Treatment Choices and Clinical Spotlight on Fexofenadine Dr. Kamal Kant Kohli1 April 2024 10:30 AM ISTAllergic rhinitis (AR) is a common inflammatory disease affecting the nasal mucosa, induced by inhaled allergens. It is clinically manifested by...
Cefuroxime in Lower Respiratory Infections: Clinical Review Dr. Kamal Kant Kohli22 March 2024 11:19 AM ISTUnmasking the Global Challenge of Lower Respiratory Tract Infections:Lower respiratory tract infections (LRTIs) are a major public health concern,...
